Financial Results
Chemcrux Enterprises Corrects Q2 FY27 Review Report
Chemcrux Enterprises submitted a corrected Limited Review Report for standalone unaudited financial results for the quarter and half year ended 30 September 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
7
Bullish
3
Bearish
31
Neutral
7
Bullish
8
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Chemicals & Petrochemicals
Specialty Chemicals
117 Cr
Moderate Risk
26.1
33.9
0.2
1.5
127.50
64.00
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q1 FY26
Chemcrux Enterprises Ltd (CHEMCRUX) is currently trading at 79.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Chemcrux Enterprises Limited primarily manufactures intermediates for bulk drugs, dyes, and pigments using specialized chemical processes like high-pressure oxidation and chlorosulfonation. The company has established a robust clientele comprising both multinational corporations and leading pharmaceutical organizations in India and has a consistent export presence in multiple countries. Chemcrux has been operational in its current corporate structure since 2000, following the acquisition of a partnership firm, though its origins date back to 1981. The company went public in March 2017, issuing equity shares to raise substantial funds for its operations and growth.
Over the past 52 weeks, Chemcrux Enterprises Ltd has traded between a low of ₹64.00 and a high of ₹127.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Chemcrux Enterprises Ltd has a market capitalization of approximately 116.93. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Chemcrux Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 26.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 116.93 Cr, Chemcrux Enterprises Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Chemcrux Enterprises Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Chemcrux Enterprises Ltd is 26.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Chemcrux reported standalone profit for the period of Rs 1.62 crore for the quarter ended 30 September 2026. This was up from Rs 79.95 lakh in the corresponding quarter ended 30 September 2025. Profit before tax was Rs 2.18 crore, compared with Rs 98.27 lakh a year earlier.
Chemcrux Enterprises reported standalone net profit after tax of ₹1.37 crore for the quarter ended June 30, 2026. This was 135.1% higher than ₹0.58 crore in Q1 FY26.
Financial Results
Chemcrux Enterprises submitted a corrected Limited Review Report for standalone unaudited financial results for the quarter and half year ended 30 September 2026.
Financial Results
Chemcrux Enterprises published newspaper notices for its standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026.
Financial Results
Chemcrux Enterprises approved unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026.
Financial Results
Chemcrux Enterprises approved unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, along with the limited review report.
